Presight Capital

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Presight invests in the most ambitious founders globally, from Seed to IPO, with a focus on deep tech and life sciences.

Venture capitalpresight.vcSince 2021-06-15

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$210M

across 1 round

LATEST ROUND

Series B · $210M · 2021-06-15

CO-INVESTORS

named beside it

Rounds

The rounds this investor is named on, who it invests beside, and where it shows up.

Umoja Biopharma, a clinical-stage leader developing in vivo CAR T cell therapies.

Series B$210M2021-06-152 [ HISTORY ]

Company	Round	Amount	Announced	Role
Umoja Biopharma Umoja Biopharma, a clinical-stage leader developing in vivo CAR T cell therapies.	Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$210M	2021-06-15	[ PART ]